These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21069393)

  • 1. Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson's disease.
    Grünblatt E; Zehetmayer S; Jacob CP; Müller T; Jost WH; Riederer P
    J Neural Transm (Vienna); 2010 Dec; 117(12):1387-93. PubMed ID: 21069393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular signature in blood identifies early Parkinson's disease.
    Molochnikov L; Rabey JM; Dobronevsky E; Bonucelli U; Ceravolo R; Frosini D; Grünblatt E; Riederer P; Jacob C; Aharon-Peretz J; Bashenko Y; Youdim MB; Mandel SA
    Mol Neurodegener; 2012 May; 7():26. PubMed ID: 22651796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creation of a gene expression classifier for predicting Parkinson's disease rate of progression.
    Rabey JM; Yarden J; Dotan N; Mechlovich D; Riederer P; Youdim MBH
    J Neural Transm (Vienna); 2020 May; 127(5):755-762. PubMed ID: 32385576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Found in transcription: accurate Parkinson's disease classification in peripheral blood.
    Karlsson MK; Sharma P; Aasly J; Toft M; Skogar O; Sæbø S; Lönneborg A
    J Parkinsons Dis; 2013; 3(1):19-29. PubMed ID: 23938308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-2 macroglobulin I1000 V polymorphism in Chinese sporadic Alzheimer's disease and Parkinson's disease.
    Tang G; Zhang M; Xie H; Jiang S; Wang Z; Xu L; Hao Y; Lin D; Lan H; Wang Y; Chen L; Ren D
    Neurosci Lett; 2002 Aug; 328(2):195-7. PubMed ID: 12133586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.
    DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG;
    Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.
    Santiago JA; Potashkin JA
    PLoS One; 2015; 10(11):e0142582. PubMed ID: 26566043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Profiling of Exosomal Proteins for Blood-based Biomarkers in Parkinson's Disease.
    Kitamura Y; Kojima M; Kurosawa T; Sasaki R; Ichihara S; Hiraku Y; Tomimoto H; Murata M; Oikawa S
    Neuroscience; 2018 Nov; 392():121-128. PubMed ID: 30266682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers in Parkinson's disease (recent update).
    Sharma S; Moon CS; Khogali A; Haidous A; Chabenne A; Ojo C; Jelebinkov M; Kurdi Y; Ebadi M
    Neurochem Int; 2013 Sep; 63(3):201-29. PubMed ID: 23791710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.
    Grünblatt E; Zander N; Bartl J; Jie L; Monoranu CM; Arzberger T; Ravid R; Roggendorf W; Gerlach M; Riederer P
    J Alzheimers Dis; 2007 Dec; 12(4):291-311. PubMed ID: 18198416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease.
    Shehadeh LA; Yu K; Wang L; Guevara A; Singer C; Vance J; Papapetropoulos S
    PLoS One; 2010 Feb; 5(2):e9104. PubMed ID: 20161708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analyses of peripheral blood leukocyte transcripts distinguish Alzheimer's, Parkinson's, control, and those at risk for developing Alzheimer's.
    Delvaux E; Mastroeni D; Nolz J; Chow N; Sabbagh M; Caselli RJ; Reiman EM; Marshall FJ; Coleman PD
    Neurobiol Aging; 2017 Oct; 58():225-237. PubMed ID: 28716532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Uric Acid Level as a Biomarker in Idiopathic and Genetic (p.A53T Alpha-Synuclein Carriers) Parkinson's Disease: Data from the PPMI Study.
    Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Pachi I; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    J Parkinsons Dis; 2020; 10(2):481-487. PubMed ID: 32176655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CARD15 variants in patients with sporadic Parkinson's disease.
    Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Juzwiak S; Kurzawski G; Tan EK; Drozdzik M
    Neurosci Res; 2007 Mar; 57(3):473-6. PubMed ID: 17174426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Weighted gene co-expression network analysis reveals specific modules and biomarkers in Parkinson's disease.
    Jin X; Li J; Li W; Wang X; Du C; Geng Z; Geng Y; Kang L; Zhang X; Wang M; Tian S
    Neurosci Lett; 2020 May; 728():134950. PubMed ID: 32276105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-variance RNAs identify Parkinson's disease molecular signature in blood.
    Chikina MD; Gerald CP; Li X; Ge Y; Pincas H; Nair VD; Wong AK; Krishnan A; Troyanskaya OG; Raymond D; Saunders-Pullman R; Bressman SB; Yue Z; Sealfon SC
    Mov Disord; 2015 May; 30(6):813-21. PubMed ID: 25786808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular markers of early Parkinson's disease based on gene expression in blood.
    Scherzer CR; Eklund AC; Morse LJ; Liao Z; Locascio JJ; Fefer D; Schwarzschild MA; Schlossmacher MG; Hauser MA; Vance JM; Sudarsky LR; Standaert DG; Growdon JH; Jensen RV; Gullans SR
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):955-60. PubMed ID: 17215369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis raises candidate genes in blood for early screening of Parkinson's disease.
    Zhang Y; Yao L; Liu W; Li W; Tian C; Wang ZY; Liu D
    Biomed Environ Sci; 2014 Jun; 27(6):462-5. PubMed ID: 24961856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.